Insider trades
Bunnage Mark E.
Bunnage Mark E. made 0 buys and 1 sale on the open market in the last 12 months at Vertex Pharmaceuticals Incorporated. Each trade with the role, price and filing.
Insider trades
Where they report
| Company | Role | Holding after | Latest trade |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | EVP, Chief Scientific Officer | 7,284 | May 15, 2026 |
Open-market trades, newest first
| Company | Date | Trade | Shares | Price | Value | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | May 15, 2026 | Sale | 33 | US$453.45 | US$14,964 | 7,284 | May 19, 2026 |